Nektar Therapeutics

NASDAQ:NKTR   4:00:00 PM EDT
25.84
+0.08 (+0.31%)
: $25.77 -0.07 (-0.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)321.59M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.49 Million
Adjusted EPS-$2.92
See more estimates
10-Day MA$21.41
50-Day MA$12.18
200-Day MA$14.40
See more pivots

Nektar Therapeutics Stock, NASDAQ:NKTR

455 Mission Bay Boulevard South, San Francisco, California 94158
United States of America
Phone: +1.415.482.5300
Number of Employees: 61

Description

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.